Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hefei Shengpu Pharmaceutical Technology is a Chinese biotechnology company focused on the research and development of innovative small molecule therapeutics. Founded in 2016 and headquartered in Hefei, Anhui Province, the company targets high-unmet-need areas such as oncology and metabolic diseases. Shengpu Pharmaceutical utilizes its internal medicinal chemistry and pharmacology expertise to advance a pipeline of proprietary drug candidates, including various kinase inhibitors. The firm is recognized as a high-tech enterprise and holds multiple patents for novel heterocyclic compounds. In addition to its internal R&D, the company provides technical consulting and technology transfer services within the pharmaceutical industry. Shengpu Pharmaceutical aims to bridge the gap between early-stage discovery and clinical application through scientific excellence and strategic regional collaborations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hefei Shengpu Pharmaceutical Technology.